BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1357875)

  • 21. Case of pemphigus with immunoglobulin G and A antibodies, binding to both the intercellular spaces and basement membrane zone.
    Hosoda S; Adachi A; Suzuki M; Yamada T; Komine M; Murata S; Ohtsuki M
    J Dermatol; 2016 Feb; 43(2):194-6. PubMed ID: 26219735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis.
    Zhou XP; Liu B; Xu Q; Yang Y; He CX; Zuo YG; Liu YH
    J Dermatol; 2016 Feb; 43(2):141-8. PubMed ID: 26300465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG4 autoantibodies induce dermal-epidermal separation.
    Mihai S; Chiriac MT; Herrero-González JE; Goodall M; Jefferis R; Savage CO; Zillikens D; Sitaru C
    J Cell Mol Med; 2007; 11(5):1117-28. PubMed ID: 17979887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IgG subclasses targeting NC16A domain of BP180 in bullous pemphigoid].
    Zhou XP; Zuo YG; Liu B; He CX; Liu YH
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(32):2529-33. PubMed ID: 24351590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.
    Messingham KN; Wang JW; Holahan HM; Srikantha R; Aust SC; Fairley JA
    Exp Dermatol; 2016 Jan; 25(1):50-5. PubMed ID: 26475989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular ionic changes induced by bullous pemphigoid IgG subclasses.
    Suzuki M; Harada S; Owaribe K; Yaoita H
    Autoimmunity; 1996; 23(3):181-97. PubMed ID: 8879454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita.
    Bernard P; Prost C; Aucouturier P; Durepaire N; Denis F; Bonnetblanc JM
    J Invest Dermatol; 1991 Aug; 97(2):259-63. PubMed ID: 2071938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
    Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
    J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
    Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
    Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG subclasses of intercellular antibodies in Brazilian pemphigus foliaceus--the relationship to complement fixing capability.
    Ogawa MM; Hashimoto T; Nishikawa T; Castro RM
    Clin Exp Dermatol; 1989 Jan; 14(1):29-31. PubMed ID: 2680177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased sensitivity and high specificity of indirect immunofluorescence in detecting IgG subclasses for diagnosis of bullous pemphigoid.
    Jankásková J; Horváth ON; Varga R; Arenberger P; Schmidt E; Ruzicka T; Sárdy M
    Clin Exp Dermatol; 2018 Apr; 43(3):248-253. PubMed ID: 29333745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A typical case of pemphigoid gestationis with a unique pattern of intercellular immunofluorescence.
    Vaughan Jones SA; Bhogal BS; Black MM; Clement M; Hashimoto T; Nishikawa T
    Br J Dermatol; 1997 Feb; 136(2):245-8. PubMed ID: 9068742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present.
    Cooper SM; Dean D; Allen J; Kirtschig G; Wojnarowska F
    Clin Exp Dermatol; 2005 Sep; 30(5):551-6. PubMed ID: 16045691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-reactive idiotypes in the sera of patients with bullous pemphigoid express anti-basement-membrane-zone activity.
    Rico MJ; Hall RP
    Dermatology; 1994; 189 Suppl 1():72-5. PubMed ID: 7519488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity purification of IgG subclasses and the distribution of thyroid auto-antibody reactivity in Hashimoto's thyroiditis.
    Weetman AP; Black CM; Cohen SB; Tomlinson R; Banga JP; Reimer CB
    Scand J Immunol; 1989 Jul; 30(1):73-82. PubMed ID: 2756340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.